Karikari Lab
  • About Us
  • Research
    • Our Focus
    • Studies
  • The Team
    • Principal Investigator
    • The Team
    • Photo Gallery
  • Publications
  • Resources
    • Biomarker Methods
    • Biobanking
    • Instrument Information
  • News
    • News
    • Community Outreach
  • Contact Us
    • Visit the lab
    • Open Positions
    • Send a Message
Select Page
Encouraging Early Intervention for Alzheimer’s in the Black Community Through an Innovative Interdisciplinary Approach

Encouraging Early Intervention for Alzheimer’s in the Black Community Through an Innovative Interdisciplinary Approach

Dec 12, 2024

Two-dozen Pitt researchers made Clarivate’s annual Highly Cited list

Two-dozen Pitt researchers made Clarivate’s annual Highly Cited list

Nov 20, 2024

Pitt Scientists Validate New Lab Test Platform for Blood Biomarkers of Alzheimer’s Disease

Pitt Scientists Validate New Lab Test Platform for Blood Biomarkers of Alzheimer’s Disease

Nov 1, 2024

Could a handheld device help catch Alzheimer’s or Parkinson’s early?

Could a handheld device help catch Alzheimer’s or Parkinson’s early?

Nov 23, 2023

By Hannah Flynn | Medical News Today There is still research to be done into the best type of biomarkers to detect Alzheimer’s disease in different types of body fluid, said Dr. Thomas K Karikari, assistant professor of psychiatry at the University of Pittsburgh, who...
New Blood Biomarker Can Predict if Cognitively Healthy Elderly Will Develop Alzheimer’s Disease

New Blood Biomarker Can Predict if Cognitively Healthy Elderly Will Develop Alzheimer’s Disease

May 29, 2023

Can Alzheimer’s be detected with a blood test? These Pitt scientists say it may help identify patients for a new drug.

Can Alzheimer’s be detected with a blood test? These Pitt scientists say it may help identify patients for a new drug.

Jan 4, 2023

By Tom Avril | The Philadelphia Inquirer The FDA may approve a new drug for Alzheimer’s as soon as this week. But policy experts warn that the health care system is ill-equipped to identify which patients might be eligible for the drug, called lecanemab, as the...
Page 2 of 5«12345»

Recent Posts

  • From Engineering to Neurodegeneration: A PhD Student’s Path to Clinical Mass Spectrometry Innovation
  • Exploring New Frontiers in Alzheimer’s Research: Reflections from AAIC Canada
  • Thomas Karikari, PhD, and Rebecca Thurston, PhD, Receive University of Pittsburgh Chancellor’s Distinguished Research Awards
  • Pitt Faculty Members Selected for 2025 Senior Vice Chancellor’s Research Seminar Series
  • Publications by Department of Psychiatry Faculty Rank Among the Top 1% of Cited Works in 2024 

Recent Comments

No comments to show.

Archives

  • September 2025
  • August 2025
  • March 2025
  • January 2025
  • December 2024
  • November 2024
  • November 2023
  • May 2023
  • January 2023
  • December 2022

Categories

  • Biomarker Methods
  • Blog
  • Job Posting
  • News

Designed by Elegant Themes | Powered by WordPress